Results 1 to 10 of about 1,222 (163)

Testing S. sonnei GMMA with and without Aluminium Salt-Based Adjuvants in Animal Models [PDF]

open access: yesPharmaceutics
Shigellosis is one of the leading causes of diarrheal disease in low- and middle-income countries, particularly in young children, and is more often associated with antimicrobial resistance.
Francesca Mancini   +9 more
doaj   +6 more sources

Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals [PDF]

open access: yesFrontiers in Molecular Biosciences, 2023
Shigellosis is leading bacterial cause of diarrhea with high prevalence in children younger than 5 years in low- and middle-income countries, and increasing number of reports of Shigella cases associated to anti-microbial resistance.
Roberta Di Benedetto   +7 more
doaj   +7 more sources

GMMA-Based Vaccines: The Known and the Unknown [PDF]

open access: yesFrontiers in Immunology, 2021
Generalized Modules for Membrane Antigens (GMMA) are outer membrane vesicles derived from Gram-negative bacteria engineered to provide an over-vesiculating phenotype, which represent an attractive platform for the design of affordable vaccines.
Francesca Micoli   +2 more
exaly   +6 more sources

Enhanced Systemic Humoral Immune Response Induced in Mice by Generalized Modules for Membrane Antigens (GMMA) Is Associated With Affinity Maturation and Isotype Switching

open access: yesVaccines, 2023
Generalized Modules for Membrane Antigens (GMMA) are outer membrane vesicles derived from Gram-negative bacteria that can be used to design affordable subunit vaccines. GMMA have been observed to induce a potent humoral immune response in preclinical and
Diego Piccioli   +2 more
exaly   +5 more sources

Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort [PDF]

open access: yesBMJ Open, 2023
Introduction Invasive non-typhoidal Salmonellosis (iNTS) is mainly caused by Salmonella enterica serovars Typhimurium and Enteritidis and is estimated to result in 77 500 deaths per year, disproportionately affecting children under 5 years of age in sub ...
  +33 more
doaj   +5 more sources

Development of a GMMA-based candidate vaccine against invasive nontyphoidal Salmonella disease [PDF]

open access: yesFrontiers in Immunology
IntroductionInvasive nontyphoidal Salmonella (iNTS) disease is one of the most common causes of bacteremia in sub-Saharan Africa (sSA), mostly affecting children less than 5 years of age and with an associated 14.7% case fatality ratio.
Francesco Citiulo   +23 more
doaj   +4 more sources

GMMA-based vaccine candidates against invasive nontyphoidal salmonellosis elicit bactericidal antibodies against a panel of epidemiologically relevant Salmonellae [PDF]

open access: yesFrontiers in Immunology
Systemic disease caused by nontyphoidal Salmonella (NTS) represents a major cause of death and morbidity, especially in young children in sub-Saharan Africa.
Daniele De Simone   +14 more
doaj   +8 more sources

Generalized Modules for Membrane Antigens (GMMA) Elicit Mild Local Reactogenicity After Intramuscular Injection in Absence of Aluminum Salt Adjuvant [PDF]

open access: yesImmunity, Inflammation and Disease
Background and Objectives Generalized modules for membrane antigens (GMMA) are outer membrane vesicles derived from gram‐negative bacteria that can be used to design affordable subunit vaccines.
Raffaella Cecchi   +10 more
doaj   +3 more sources

GMMA as adjuvant and carrier for mucosal delivery of group A streptococcus glycoconjugate vaccine [PDF]

open access: yesHuman Vaccines & Immunotherapeutics
Group A streptococcus (GAS) infection is usually initiated by colonization of mucosal sites such as the pharynx, followed by invasion and systemic dissemination.
James Ozanne   +10 more
doaj   +3 more sources

Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trialResearch in context [PDF]

open access: yesEBioMedicine
Summary: Background: Invasive non-typhoid Salmonella (iNTS) is a leading cause of morbidity and mortality in sub-Saharan Africa. We assess the safety and immunogenicity of an outer membrane vesicle vaccine (iNTS-GMMA) derived from the two most common ...
Brama Hanumunthadu   +40 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy